
Market opinion : Equivalence & Brexit : Jannah Patchay
SEPARATE BUT EQUAL Jannah Patchay, Markets Evolution, assesses the equivalence regime with a post Brexit lens. At the time of writing,
SEPARATE BUT EQUAL Jannah Patchay, Markets Evolution, assesses the equivalence regime with a post Brexit lens. At the time of writing,
CHANGING RELATIONSHIPS. Silvano Stagni, Managing Director of Perpetual Motion Consulting and Research, asks whether we have the data to navigate
DATA WILL TRIGGER THE CHANGE EVERYBODY HAS BEEN PREDICTING. By Silvano Stagni, Managing Director of PMCR – Perpetual Motion Consulting
REVERSING DIRECTION. MiFID II may be grabbing all the limelight but Jannah Patchay, Markets Evolution argues now is the time
THE DAY AFTER TOMORROW… Jannah Patchay at Markets Evolution looks ahead at what the implementation of MiFID II will mean
THE TICKING CLOCK. Jannah Patchay, Managing Director, Markets Evolution looks at the ramifications of Brexit on the OTC market. Like
THE HARMONISATION UTOPIA. Eman Galea, Research Analyst at JWG looks at the challenges behind standardisation. With increasingly complex and intrusive
THE SURVEILLANCE CHALLENGE. Daniel Simpson, head of research at JWG-IT, outlines the many hurdles presented under MAR and MiFID II
WHO SEES THE BIG PICTURE? By Jannah Patchay, Director, Agora Global Consultants. We live in interesting times indeed. Between Brexit,
TRADING, POST MiFID. Sassan Danesh, Co-Chair, OTC Products Committee, FIX Trading Community outlines what he sees are the priorities for